Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,871 | 5,923 | 8,714 | 9,526 | 7,286 |
| Marketable Securities | 3,007 | 7,020 | 7,004 | 12,080 | 12,046 |
| Receivables | 663 | 332 | 1,093 | 722 | 1,060 |
| TOTAL | $10,541 | $13,275 | $16,811 | $22,328 | $20,392 |
| Non-Current Assets | |||||
| PPE Net | 71 | 84 | 88 | 93 | 91 |
| Investments And Advances | 18 | 11 | 56 | 58 | 33 |
| TOTAL | $89 | $95 | $144 | $151 | $124 |
| Total Assets | $10,630 | $13,370 | $16,955 | $22,479 | $20,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,931 | 1,999 | 1,468 | 2,175 | 2,514 |
| TOTAL | $1,931 | $1,999 | $1,468 | $2,175 | $2,514 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 125 | 70 |
| TOTAL | $N/A | $N/A | $N/A | $125 | $70 |
| Total Liabilities | $1,931 | $1,999 | $1,468 | $2,300 | $2,584 |
| Shareholders' Equity | |||||
| Common Shares | 45 | 45 | 45 | 45 | 39 |
| Retained earnings | -39,809 | -36,736 | -32,066 | -28,381 | -23,787 |
| TOTAL | $8,699 | $11,371 | $15,487 | $20,179 | $17,932 |
| Total Liabilities And Equity | $10,630 | $13,370 | $16,955 | $22,479 | $20,516 |